ConductScience.org, home

Paper6440451

Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.

Meares CF and 5 others. Anal Biochem, 1984. Cited by 359 papers, by iCite.

Cite this record

ConductScience Library. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Papers, record 6440451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6440451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
PubMed
Journal
Anal Biochem
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
359
iCite
Relative citation ratio, by iCite
11.1
iCite
Revised in PubMed
2021-01-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Meares CFC F
2McCall MJM J
3Reardan DTD T
4Goodwin DAD A
5Diamanti CIC I
6McTigue MM

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Chelating AgentsMajor topic
Cross-Linking ReagentsMajor topic
MetalsMajor topic
Animals
Antibody Affinity
B-Lymphocytes
Chromatography, High Pressure Liquid
Chromatography, Thin Layer
Cobalt Radioisotopes
Edetic Acid
Indium
Lymph Nodes
Magnetic Resonance Spectroscopy
Mice
Mice, Inbred BALB C
Protein Binding
Radioisotopes
Spectrophotometry, Infrared
Spectrophotometry, Ultraviolet

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA00462NCI NIH HHSUnited StatesK04CA000462PubMed and NIHNIH RePORTER
CA16861NCI NIH HHSUnited StatesR01CA016861PubMed and NIHNIH RePORTER
CA18343NCI NIH HHSUnited StatesPubMedPubMed
R37CA016861NIHNIH RePORTER

Download CSV of grants

Cited by67

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 359 citations.

PMIDTitleJournalYearIn PapersSource
42325638Side-by-Side Comparison of Different Thiol Bioconjugation Strategies for the Chemoselective Radiolabeling of Human Serum Albumin with Zirconium-89.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42325638PubMed
41941715Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity.J Med Chem2026https://conductscience.org/library/papers/41941715PubMed
41872337A phase I study to evaluate the dosimetry and safety of [89Zr]Zr-DFO-AP-101, a new antibody-based radiopharmaceutical to detect misfolded SOD1 in amyotrophic lateral sclerosis.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/41872337PubMed
40881666Development and Use of a Galectin-1-Specific Nanobody for Tumor Imaging and Elucidating the Role of Galectin‑1 in Cancer.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40881666PubMed
40208951Development of Galectin-7-Specific Nanobodies: Implications for Immunotherapy and Molecular Imaging in Cancer.J Med Chem2025https://conductscience.org/library/papers/40208951PubMed
39667814Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model.J Nucl Med2025https://conductscience.org/library/papers/39667814PubMed
39174789Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer.Mol Imaging Biol2024https://conductscience.org/library/papers/39174789PubMed
39065579Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging.Pharmaceutics2024https://conductscience.org/library/papers/39065579PubMed
38675440Preparation of a Zirconium-89 Labeled Clickable DOTA Complex and Its Antibody Conjugate.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38675440PubMed
38376808Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer.Eur J Nucl Med Mol Imaging2024https://conductscience.org/library/papers/38376808PubMed
38366964A Kinetically Controlled Bioconjugation Method for the Synthesis of Radioimmunoconjugates and the Development of a Domain Mapping MS-Workflow for Its Characterization.Bioconjug Chem2024https://conductscience.org/library/papers/38366964PubMed
37552575Evaluation of [89Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer.Mol Pharm2023https://conductscience.org/library/papers/37552575PubMed
34959652Humanization, Radiolabeling and Biodistribution Studies of an IgG1-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34959652PubMed
34298682A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen.Cancers (Basel)2021https://conductscience.org/library/papers/34298682PubMed
34014767In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab.Cancer Biother Radiopharm2021https://conductscience.org/library/papers/34014767PubMed
33574346Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT.Sci Rep2021https://conductscience.org/library/papers/33574346PubMed
33537102Abraxane-induced bone marrow CD11b+ myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with 64Cu-labeled anti-CD11b and prevented by anti-CSF-1.Theranostics2021https://conductscience.org/library/papers/33537102PubMed
32123103Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32123103PubMed
31044647Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.Mol Imaging2019https://conductscience.org/library/papers/31044647PubMed
31015228Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma.Cancer Res2019https://conductscience.org/library/papers/31015228PubMed

See all 67 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6440451

GET https://conductscience.org/api/papers/v1/6440451/cited_by?page=2